HONG KONG – Tetraphase Pharmaceuticals Inc., of Watertown, Mass., said its Chinese partner, Everest Medicines Ltd., has filed an application with Chinese regulators to initiate the phase III trial of its lead product eravacycline in complicated intra-abdominal infections (cIAIs).